ロード中...
Sensitizing human multiple myeloma cells to the proteasome inhibitor bortezomib by novel curcumin analogs
The proteasome plays a vital role in the degradation of proteins involved in several pathways including the cell cycle, cellular proliferation and apoptosis and is a validated target in cancer treatment. Bortezomib (Velcade(®), PS-341) is the first US FDA approved proteasome inhibitor anticancer dru...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3307794/ https://ncbi.nlm.nih.gov/pubmed/22012631 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2011.814 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|